U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

(Mark One)
[x] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT
OF 1934
                 For the quarterly period ended September 30, 2005

[ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

     For the transition period from ___________ to ___________

                       Commission file number: 000-29087

                                Datascension, Inc.
                  --------------------------------------------
                 (Name of small business issuer in its charter)

        Nevada                                               87-0374623
- ------------------------                                   --------------
(State or other jurisdiction of                            (IRS Employer
incorporation or organization)                            Identification No.)

145 S. State College Blvd, Suite 350, Brea, CA                 92821
- -----------------------------------------------              ---------
    (Address of principal executive offices)                 (Zip Code)

                    714-482-9750 (Telephone)  714-482-9751 (Fax)
                    --------------------------------------------
                           (Issuer's telephone number)

                 6330 McLeod Drive, Suite 1, Las Vegas, NV 89120
          ----------------------------------------------------------------
(Former name, former address and former fiscal year, if changed since last
report)

      Check  whether  the  issuer (1) filed all reports required to be filed by
Section 13 or 15(d) of the Exchange  Act during the past 12 months (or for such
shorter period that the registrant was  required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.Yes [X] No[ ]

Indicate by check mark whether the registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act). (Check one): Yes [ ] No [X]

               APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
                    PROCEEDING DURING THE PRECEDING FIVE YEARS

Check whether the Registrant filed all documents and reports required to be
filed by Section 12, 13 or 15(d) of the Exchange Act after the distribution of
securities under a plan confirmed by a court.
                                                              Yes [ ] No [ ]

                   APPLICABLE ONLY TO CORPORATE ISSUERS

The Registrant has 17,232,290 outstanding, par value $.001 per share as of
November 21, 2005.  The Registrant has 505,900 shares of Preferred Stock Series
B issued and outstanding as of November 21, 2005.

Transitional Small Business Disclosure Format (check one): Yes [ ] No [X]



                                       2







                               TABLE OF CONTENTS

                                                                      Page No.

PART I.  FINANCIAL INFORMATION

Item 1.   Financial Statements......................................     4
          Balance Sheet (unaudited).................................     F1
          Statements of Operations (unaudited)......................     F2
          Statements of Cash Flows (unaudited)......................     F3
          Notes to Financial Statements............................. F4-F10

Item 2.  Management's Discussion and Analysis of Plan
           of Operation.............................................     5

Item 3. Controls and Procedures.....................................     8


PART II. OTHER INFORMATION

Item 1.   Legal Proceedings.........................................     8

Item 2.   Unregistered Sales of Equity and Use of Proceeds..........     8

Item 3.   Defaults upon Senior Securities...........................    10

Item 4.   Submission of Matters to a Vote of Security Holders.......    10

Item 5.   Other Information..........................................   10

Item 6.   Exhibits and Reports on Form 8-K...........................   10

Signatures...........................................................   11








                                       3



                            PART I. FINANCIAL INFORMATION

Item 1. Financial Statements.

      The  condensed  financial  statements  of  Datascension,  Inc.,  ("DSEN")
included herein have been prepared  in  accordance  with  the  instructions  to
quarterly  reports  on Form 10-QSB pursuant to the rules and regulations of the
Securities and Exchange  Commission.   Certain  information  and  footnote data
necessary for fair presentation of financial position and results of operations
in  conformity  with  accounting  principles  generally accepted in the  United
States of America have been condensed or omitted.  It  is  therefore  suggested
that  these  financial  statements  be read in conjunction with the summary  of
significant accounting policies and notes  to  financial statements included in
DSEN's Annual Report on Form 10-KSB for the year ended December 31, 2004.

      In the opinion of management, all adjustments  necessary in order to make
the financial position, results of operations and changes in financial position
at September 30, 2005, and for all periods presented not  misleading  have been
made.   The  results of operations for the period ended September 30, 2005  are
not necessarily  an indication of operating results to be expected for the full
year ending December 31, 2005.






                                                               


                        ASSETS

                                                         9/30/05     12/31/04
   CURRENT ASSETS:
Cash                                                       $203,724     $556,593
Accounts receivable                                       1,519,526    1,533,969
Prepaid expenses                                             18,810      192,185
Investment in Century Innovations                           108,469      108,469
							-----------   ----------
   TOTAL CURRENT ASSETS                                  $1,850,529   $2,391,216

Property and Equipment, net of accumulated
   depreciation                                             995,543      681,346

   OTHER ASSETS:
                                                                  -    1,346,145
Asset held for sale (see notes)                                   -    1,015,014
Website assets, net of amortization                           4,520        4,520
Deposits                                                     20,249       25,399
Goodwill                                                  1,692,782    1,692,782
							-----------   ----------
   TOTAL OTHER ASSETS                                     1,717,551    4,083,860

TOTAL ASSETS                                             $4,563,623   $7,156,422
							===========   ==========

         LIABILITIES AND STOCKHOLDERS' EQUITY

                                                         9/30/05     12/31/04
   CURRENT LIABILITIES:
Accounts payable                                            $81,211     $135,533
Accrued expenses                                          1,383,272    1,390,880
Notes payable, related party                                 21,000       60,038
Short term notes payable                                     65,101      121,742
Current portion of long-term notes payable                        -      116,207
							-----------   ----------
   TOTAL CURRENT LIABILITIES                             $1,550,584   $1,824,400

  LONG-TERM DEBT
Convertible debt, net of current portion                    931,970       77,344
Derivative liability                                        735,921    3,017,222
Warrant liability                                           507,977    1,785,877
Long-term notes payable, net of current portion             278,178      103,548
							-----------   ----------
  TOTAL LONG-TERM DEBT                                    2,454,046    4,983,991

  TOTAL LIABILITIES                                       4,004,630    6,808,391

   STOCKHOLDERS' EQUITY:
  Common stock:
Common stock, $0.001 par value, 200,000,000
  shares authorized; 17,232,290 and 16,257,290 shares
  issued, 17,111,457 and 16,161,457 outstanding at
  September 30, 005 and December 31, 2004, respectively     160,825      159,875
  Additional paid-in capital-common stock                11,503,345   11,029,295
   Preferred stock Series B:
Preferred stock, $0.001 par value, 10,000,000
shares authorized; 508,500 Series B shares
issued and outstanding at December 31, 2004                     506          506
  Additional paid-in capital-preferred Series B             481,994      481,994
  Subscriptions receivable                                (475,000)    (119,063)
  Treasury stock, at cost; 95,833 at December 31, 2004    (134,388)    (134,388)
  Accumulated deficit                                  (10,978,290) (11,070,189)
							-----------   ----------
TOTAL STOCKHOLDERS' EQUITY                                  558,993      348,031
							-----------   ----------
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY               $4,563,623   $7,156,422
							===========   ==========


		The accompanying notes to the financial statements
	should be read in conjunction with the above financial statements.


				F-1





                                                                     

                                      FOR THE       FOR THE       FOR THE       FOR THE
                                   3 MONTHS ENDED3 MONTHS ENDED9 MONTHS ENDED9 MONTHS ENDED
                                      9/30/05       9/30/04       9/30/04       9/30/05

REVENUE                                $2,365,454    $2,101,033    $6,380,488    $6,864,011

COST OF GOODS SOLD                      2,127,257     1,663,996     5,091,217     5,718,341
				       ----------    ----------    ----------    ----------

GROSS PROFIT                              238,197       437,037     1,289,271     1,145,670

EXPENSES:
Selling, general and administrative      $560,697      $371,393    $1,014,082    $1,409,080
Depreciation                               44,888        85,646       256,133       131,885
				       ----------    ----------    ----------    ----------
TOTAL EXPENSES                            605,585       457,039     1,270,215     1,540,965

OPERATING INCOME                        (367,388)      (20,002)        19,056     (395,295)

OTHER INCOME (EXPENSE):
Interest income                               281            61           466           610
Forgiveness of debt                             -        54,039        54,039         2,962
Other income                                3,000         3,250         5,435         6,382
Interest expense                          (64,671)      (20,697)      (68,765)     (287,242)
Other Income (Expense) from convertible    33,199             -             -     2,298,958
Interest (expense) from convertible      (176,755)            -             -      (530,645)
Other income                                    -             -         2,699             -
				       ----------    ----------    ----------    ----------
TOTAL OTHER INCOME                      (204,946)        36,653       (6,126)     1,491,025

NET INCOME (LOSS)                      $(572,334)       $16,651       $12,930    $1,095,730

BASIC WEIGHTED AVERAGE NUMBER
OF COMMON SHARES OUTSTANDING           17,207,290    15,944,790    15,510,066    17,099,415

DILUTED WEIGHTED AVERAGE NUMBER
OF COMMON SHARES OUTSTANDING           28,617,290    15,944,790    15,510,066    28,390,550

BASIC NET INCOME PER SHARE               $(0.033)        $0.001        $0.001        $0.064

DILUTED NET INCOME PER SHARE             $(0.020)        $0.001        $0.001        $0.039



		The accompanying notes to the financial statements
	should be read in conjunction with the above financial statements.


				F-2





           

						 For the 9 months ended
						    9/30/05    9/30/04

Cash Flows From Operating Activities:
Net income					  $1,095,730   $12,930
Adjustments to reconcile net income to net
cash provided by operating activities:
    Issued for services				           -    44,000
Depreciation and amortization			     131,885   256,132
 (Decrease) in asset held for sale		   1,015,014         -
 Distribution of asset held for sale		 (1,003,831)         -
(Increase) Decrease in accounts receivable	      14,443 (212,093)
Increase in inventory				           -     1,946
Increase in prepaid expenses			     173,375  (46,326)
Increase in deposits				       5,150    23,492
Decrease in accounts payable			    (54,322)  (49,595)
Decrease in accrued expenses			     (7,608)    60,629
						------------ ---------
Net cash used by operating activities		  $1,369,836   $91,115

Cash Flows From Investing Activities:
(Increase) Decrease in notes receivable		           -   167,294
Purchase of property and equipment		   (446,082)  (12,897)
						------------ ---------
Net cash used by investing activities		   (446,082)   154,397

Cash Flows From Financing Activities:
Increase in notes payable			       1,782 (341,121)
Increase (Decrease) in related party payable	    (39,038)         -
Increase (Decrease) in convertible debt		     854,626         -
Increase (Decrease) in stock subscriptions	     119,063         -
Cash in distributed subsidiary			                10,661
Issuance of common stock			           -   100,306
Change in warrant liability			 (1,277,900)         -
Change in derivative liability			 (2,281,301)         -
Change in call option value			   1,346,145         -
(Decrease) Increase in line of credit		           -   (3,948)
						------------ ---------
Net cash provided by financing activities	 (1,276,623) (234,102)
						------------ ---------
Net Increase in Cash				   (352,869)    11,410

Balance, Beginning				     556,593   122,891
						------------ ---------
Balance, Ending					    $203,724  $134,301
						============ =========

Interest Paid					    $287,242   $68,765
Taxes Paid					          $-        $-





		The accompanying notes to the financial statements
	should be read in conjunction with the above financial statements.


				F-3



                              DATASCENSION, INC.
                  NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 1 - HISTORY AND ORGANIZATION OF THE COMPANY

Datascension,  Inc.  (formerly known as Nutek, Inc.) was incorporated in August
1991 under the laws of  the  State of Nevada as Nutek, Inc. (the "Company") and
is engaged in the market research industry.

Datascension International, Inc. and related assets were purchased on September
27, 2001 for $2,200,000 using company shares at fair market value. Datascension
International, Inc. is a data solutions company representing a unique expertise
in the collecting, storage, processing,  and  interpretation  of  data.  During
2002, Datascension International, Inc. expanded operations into Costa Rica.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Accounting
The  Company's  policy  is  to  prepare the financial statements on the accrual
basis of accounting. The fiscal year end is December 31.

Cash and Cash Equivalents
Cash and cash equivalents consist  of highly liquid investments with maturities
of three months or less when purchased.

Net Income Per Share

Basic net income per share is computed  using  the  weighted  average number of
shares  of common stock outstanding for the period end. The net  income  (loss)
for the period  end  is  divided  by  the  weighted  average  number  of shares
outstanding for that period to arrive at net income per share.

Diluted  net income per share reflects the potential dilution that could  occur
if the securities  or  other  contracts to issue common stock were exercised or
converted into common stock.

In the opinion of management, all  adjustments  necessary  in order to make the
financial position, results of operations and changes in financial  position at
September 30, 2005, and for all periods resented not misleading have been made.
The  results  of  operations  for  the period ended September 30, 2005 are  not
necessarily an indication of operating results to be expected for the full year
ending December 31, 2005.

				F-4


NOTE 3 - PROPERTY AND EQUIPMENT

 Property and equipment are made up of the following as of September 30, 2005:

      Equipment and machinery      $     472,500
      Office equipment                 1,068,138
      Leasehold improvements               9,959
      Accumulated depreciation          (555,053)
                                    -------------
                                   $     995,543

The company purchased predictive dialers for a total cost of $125,000 during
the three months ended June 30, 2005.

NOTE 4 - NOTES PAYABLE

NOTES PAYABLE - $200,000, MAY 2005

On May 18, 2005, the company received $200,000 in the form of a promissory note
at 12% per year. The note does not specify a term for when it is due.

NOTES PAYABLE - $1,875,000, NOVEMBER 2004

In November 2004, the Company issued $1,875,000 in principal amount of Notes to
third  parties.  As  part  of the financing  transaction,  the  Company  issued
warrants to purchase 3,125,000  shares  of common stock at a per share purchase
price of $0.30 per share.

The Notes accrue interest at a rate of prime  + 3% per annum. The Notes are due
and payable in November 2007.  The convertible  note and warrant documents were
filed in an 8-K by the Company on November 23, 2004.  The Note was entered into
pursuant to the terms of a subscription agreement between  the  Company and the
Holder, which was also included in the 8-K filed on November 23, 2004.

Interest payable on this Note shall accrue at the "prime rate" published in The
Wall  Street  Journal from time to time, plus three percent (3%). The  interest
rate shall be increased  or  decreased  as the case may be for each increase or
decrease in the prime rate in an amount equal  to  such increase or decrease in
the prime rate; each change to be effective as of the day of the change in such
rate.  The Interest Rate shall not be less than eight  percent  (8%).  Interest
shall be  calculated  on the basis of a 360 day year. Interest on the Principal
Amount shall be payable  monthly,  in  arrears, commencing the first day of the
month after 120 days from the closing and  on the first day of each consecutive
calendar month thereafter (each, a "Repayment  Date") and on the Maturity Date,
whether by acceleration or otherwise.

Amortizing payments of the outstanding Principal  Amount  of  this  Note  shall
commence  on  the first (1st) Repayment Date and shall recur on each succeeding
Repayment Date  thereafter  until the Principal Amount has been repaid in full,
whether by the payment of cash  or  by  the  conversion  of such principal into
Common  Stock  pursuant to the terms of the note. On each Repayment  Date,  the
Company should make  payments to the Holder in the amount of one- thirty-second
(1/32nd) of the initial  Principal  Amount  (the  "Monthly  Principal Amount"),
together with any accrued and unpaid interest then due on such  portion  of the
Principal Amount plus any and all other amounts which are then owing under this
Note that have not been paid (the Monthly Principal Amount, together with  such
accrued  and unpaid interest and such other amounts, collectively, the "Monthly
Amount").  Any  Principal  Amount that remains outstanding on the Maturity Date
shall be due and payable on the Maturity Date.

Following the occurrence and  during the continuance of an Event of Default (as
discussed  in  the  Note),  the  annual   interest   rate  on  the  Note  shall
automatically be increased by two percent (2%) per month,  and  all outstanding
obligations  under  this  Note,  including  unpaid interest, shall continue  to
accrue interest from the date of such Event of  Default  at  such interest rate
applicable to such obligations until such Event of Default is cured or waived.

				F-5

The  Holder  shall  convert  into  shares  of  Common  Stock  all at the  Fixed
Conversion  Price  or  the  maximum portion of the Monthly Amount due  on  each
Repayment Date provided that  the  average closing price of the Common Stock as
reported by Bloomberg, L.P. on the Principal  Market (as defined below) for the
twenty (20) consecutive trading days immediately  preceding such Repayment Date
shall  be  greater  than  or  equal  to  15% above the Fixed  Conversion  Price
("Conversion Criterion"). The Monthly Amount  due  on a Repayment Date that the
Holder has not been able to convert into shares of Common  Stock due to failure
to  meet  the  Conversion  Criterion  shall  be  paid  by the Borrower  at  the
Borrower's  election  (i)  in cash at the rate of 104% of such  Monthly  Amount
otherwise due on such Repayment  Date  within  three  (3)  business days of the
applicable  Repayment  Date, or (ii) in registered, unlegended,  free-  trading
Common Stock at an applied  conversion  rate equal to eighty-five percent (85%)
of the average of the five (5) lowest closing bid prices of the Common Stock as
reported by Bloomberg L.P. for the twenty  (20)  trading  days  preceding  such
Repayment Date.

Call  Option  -  The  Company will have the option of prepaying the outstanding
Principal Amount ("Optional Redemption"), in whole or in part, by paying to the
Holder a sum of money equal  to  one  hundred  twenty  percent  (120%)  of  the
Principal  Amount  to  be  redeemed,  together with accrued but unpaid interest
thereon

Holder's Conversion Rights. The Holder  shall  have  the  right,  but  not  the
obligation,  to  convert  all  or any portion of the then aggregate outstanding
Principal Amount of this Note, together with interest and fees due hereon, into
shares of Common Stock.

The $1,875,000 in proceeds from the financing transaction were allocated to the
conversion option, call option and  to  the  warrants  based  upon  their  fair
values.  After  the  latter  allocations,  there  was  no remaining value to be
allocated to the Note on the financial statements. The company took a charge to
interest expense for $330,398 related to the amount of the liabilities over the
proceeds from the debt.

The debt discount is being accreted using the effective  interest  method  over
the term of the note.

The value of the discount on the converted notes on the books is being accreted
over  the term of the note (three years). For the years ended December 31, 2004
and 2003,  the  Company accreted $58,594 and $0, respectively, of debt discount
related to the Notes. For the nine months ended September 30, 2005, the Company
accreted $510,074 of the debt discount related to the Notes.

WARRANTS ISSUED

The estimated fair value of the 3,125,000 warrants at issuance (11/11/2004) was
$936,714 and has  been  classified as a derivative instrument and recorded as a
liability  on  the  Company's   balance   sheet   in  accordance  with  current
authoritative guidance. The estimated fair value of the warrants was determined
using   the  Black-Scholes  option-pricing  model.  The  model   uses   several
assumptions  including:  historical  stock price volatility, risk-free interest
rate, remaining maturity, and the closing  price  of the Company's common stock
to determine estimated fair value of the derivative  liability.  In valuing the
warrants at December 31, 2004, the company used the closing price  of $0.65 and
the exercise price of $0.30. In accordance with the provisions of SFAS No. 133,
Accounting  for  Derivative Instruments, the Company is required to adjust  the
carrying value of  the  instrument to its fair value at each balance sheet date
and recognize any change  since  the prior balance sheet date as a component of
Other Income (Expense). The warrant  derivative liability at December 31, 2004,
had increased to a fair value of $1,785,877,  due in part to an increase in the
market value of the Company's common stock to $0.65  from  $0.40  at  issuance,
which  resulted in an "other expense" item of $849,163 on the Company's  books.
For the  nine months ended September 30, 2005, the warrant derivative liability
had decreased  to  a value of $474,525, due in part to a decrease in the market
value of the Company's  common  stock to $0.40 from $0.65 at December 31, 2004,
which resulted in an "other income"  item  of  $1,311,352  for  the nine months
ended September 30, 2005.

The  recorded  value  of  such  warrants  can fluctuate significantly based  on
fluctuations in the market value of the underlying  securities of the issuer of
the warrants.

In  accordance  with  Statement  of  Financial Accounting  Standards  No.  133,
"Accounting for Derivative Instruments  and  Hedging  Activities,"  as  amended
("SFAS  133"),  the  holder's  conversion  right  provision  (collectively, the
features)  contained  in  the  terms  governing  the Notes are not clearly  and
closely related to the characteristics of the Notes.  Accordingly, the features
qualified as embedded derivative instruments at issuance  and,  because they do
not qualify for any scope exception within SFAS 133, they were required by SFAS
133  to  be  accounted for separately from the debt instrument and recorded  as
derivative financial instruments.


				F-6

HOLDER'S CONVERSION RIGHT

Pursuant to the  terms  of the Notes, these notes are convertible at the option
of the holder, at anytime  on  or  prior  to  maturity. The holder's conversion
right represents an embedded derivative that is  required  to  be accounted for
apart  from  the  underlying Notes. At issuance of the Notes (11/11/2004),  the
holder's conversion  right  had  an estimated initial fair value of $1,409,649,
which was recorded as a discount to the Notes and a derivative liability on the
consolidated balance sheet. In subsequent periods, if the price of the security
changes, the embedded derivative financial  instrument  related to the holder's
conversion right will be adjusted to fair value with the  corresponding  charge
or  credit to other expense or income. The estimated fair value of the holder's
conversion  right  was determined using the Black-Scholes option-pricing model.
The  model  uses  several   assumptions   including:   historical  stock  price
volatility, risk-free interest rate, remaining maturity,  and the closing price
of  the  Company's  common  stock  to  determine  estimated fair value  of  the
derivative liability. In valuing the holder's conversion  right at December 31,
2004,  the  company used the closing price of $0.65 and the exercise  price  of
$0.30. For the  year ended December 31, 2004, due in part to an increase in the
market value of the Company's common stock to $0.65 from $0.40 at issuance, the
Company recorded an "other expense" on the consolidated statement of operations
for the change in  fair value of the holder's conversion right of approximately
$1,607,573. At December  31,  2004,  the  estimated  fair value of the holder's
conversion  right  was  approximately  $3,017,222. For the  nine  months  ended
September  30,  2005, the estimated value  of  the  holder's  conversion  right
decreased to $723,903,  thus the company recorded an "other income" item on the
consolidated statement of  operations  for  the  change  in  fair  value of the
holder's conversion right of $2,293,319 for the nine months ended September 30,
2005.

The  recorded  value of the holder's conversion right related to the Notes  can
fluctuate significantly  based  on  fluctuations  in  the  fair  value  of  the
Company's common stock.

COMPANY'S CALL OPTION ON DEBT

Pursuant to the terms of the Notes, the Company has the option of prepaying the
outstanding Principal Amount in whole or in part, by paying to the Holder a sum
of  money equal to one hundred twenty percent (120%) of the Principal Amount to
be redeemed,  together with accrued but unpaid interest thereon and any and all
other sums due.

The company's call option represents an embedded derivative that is required to
be accounted for  apart  from  the  underlying  Notes. At issuance of the Notes
(11/11/2004), the company's call option had an estimated  initial fair value of
$140,965, which was recorded as a asset on the consolidated  balance sheet.  In
subsequent  periods,  if  the  price  of  the  security  changes, the  embedded
derivative financial instrument related to the company's call  option  will  be
adjusted to fair value with the corresponding charge or credit to other expense
or  income.  The  estimated  fair  value  of  the holder's conversion right was
determined using the Black-Scholes option-pricing model. The model uses several
assumptions  including: historical stock price volatility,  risk-free  interest
rate, remaining  maturity,  and the closing price of the Company's common stock
to determine estimated fair value  of  the  derivative  asset.  In  valuing the
holder's  conversion  right at December 31, 2004, the company used the  closing
price of $0.65 and the exercise price of $0.30. For the year ended December 31,
2004, due in part to an  increase  in  the market value of the Company's common
stock to $0.65 from $0.40 at issuance, the  Company  recorded an "other income"
item on the consolidated statement of operations for the  change  in fair value
of the company's call option of approximately $1,205,180. At December 31, 2004,
the  estimated  fair  value  of  the  company's  call  option was approximately
$1,346,145. For the nine months ended September 30, 2005,  the  estimated value
of  the  company's  call  option decreased to $0, thus the company recorded  an
"other expense" item on the consolidated statement of operations for the change
in fair value of the company's  call  option  of $1,346,145 for the nine months
ended September 30, 2005.

The  recorded  value of the company's call option  related  to  the  Notes  can
fluctuate significantly  based  on  fluctuations  in  the  fair  value  of  the
Company's common stock.

NOTES PAYABLE - $125,000, MARCH 2005

In  March  2005,  the  Company  issued $125,000 in principal amount of Notes to
third  parties.  As  part  of the financing  transaction,  the  Company  issued
warrants to purchase 300,000  shares  of  common  stock at a per share purchase
price  of  $0.50 per share. The Warrants shall be exercisable  until  five  (5)
years after the Issue Date of the Warrants.

The Notes accrue  interest  at  a  rate  12%  per  annum. The Notes are due and
payable in March 2007.

Interest shall be calculated on the basis of a 360 day  year.  Interest  on the
Principal Amount shall be payable monthly, in arrears, commencing the first day
of  the  month  after  120  days  from the closing and on the first day of each
consecutive calendar month thereafter  (each,  a  "Repayment  Date") and on the
Maturity Date, whether by acceleration or otherwise.

Call  Option  -  The Company will have the option of prepaying the  outstanding
Principal Amount ("Optional Redemption"), in whole or in part, by paying to the
Holder a sum of money  equal  to  one  hundred  twenty  percent  (120%)  of the
Principal  Amount  to  be  redeemed,  together with accrued but unpaid interest
thereon

Holder's Conversion Rights. The Holder  shall  have  the  right,  but  not  the
obligation,  to  convert  all  or any portion of the then aggregate outstanding
Principal Amount of this Note, together with interest and fees due hereon, into
shares of Common Stock.

The $125,000 in proceeds from the  financing  transaction were allocated to the
conversion  option,  call  option and to the warrants  based  upon  their  fair
values. After the latter allocations,  the  company  allocated  $39,098  to the
carrying  value  of  the  debt.  That debt discount is being accreted using the
effective interest method over the term of the note.

The value of the discount on the converted notes on the books is being accreted
over the term of the note (three years).  For  the  nine months ended September
30,  2005,  the Company accreted $20,571 of the debt discount  related  to  the
Notes.



				F-7

WARRANTS ISSUED

The estimated  fair  value  of the 300,000 warrants at issuance (3/31/2005) was
$56,785 and has been classified  as  a  derivative instrument and recorded as a
liability  on  the  Company's  balance  sheet   in   accordance   with  current
authoritative guidance. The estimated fair value of the warrants was determined
using   the   Black-Scholes   option-pricing  model.  The  model  uses  several
assumptions including: historical  stock  price  volatility, risk-free interest
rate, remaining maturity, and the closing price of  the  Company's common stock
to determine estimated fair value of the derivative liability.  In  valuing the
warrants at March 31, 2005, the company used the closing price of $0.50 and the
exercise  price  of  $0.50. In accordance with the provisions of SFAS No.  133,
Accounting for Derivative  Instruments,  the  Company is required to adjust the
carrying value of the instrument to its fair value  at  each balance sheet date
and recognize any change since the prior balance sheet date  as  a component of
Other  Income  (Expense).  For  the  nine months ended September 30, 2005,  the
warrant derivative liability had decreased  to  a value of $33,452, due in part
to a decrease in the market value of the Company's  common  stock to $0.32 from
$0.50 at March 31, 2005, which resulted in an "other income" item of $23,333.

The  recorded  value  of  such  warrants can fluctuate significantly  based  on
fluctuations in the market value  of the underlying securities of the issuer of
the warrants.

In  accordance  with  Statement  of Financial  Accounting  Standards  No.  133,
"Accounting for Derivative Instruments  and  Hedging  Activities,"  as  amended
("SFAS  133"),  the  holder's  conversion  right  provision  (collectively, the
features)  contained  in  the  terms  governing  the Notes are not clearly  and
closely related to the characteristics of the Notes.  Accordingly, the features
qualified as embedded derivative instruments at issuance  and,  because they do
not qualify for any scope exception within SFAS 133, they were required by SFAS
133  to  be  accounted for separately from the debt instrument and recorded  as
derivative financial instruments.

HOLDER'S CONVERSION RIGHT

Pursuant to the  terms  of the Notes, these notes are convertible at the option
of the holder, at anytime  on  or  prior  to  maturity. The holder's conversion
right represents an embedded derivative that is  required  to  be accounted for
apart  from  the  underlying  Notes.  At  issuance of the Notes (3/31/05),  the
holder's conversion right had an estimated initial fair value of $29,117, which
was  recorded as a discount to the Notes and  a  derivative  liability  on  the
consolidated balance sheet. In subsequent periods, if the price of the security
changes,  the  embedded derivative financial instrument related to the holder's
conversion right  will  be adjusted to fair value with the corresponding charge
or credit to other expense  or income. The estimated fair value of the holder's
conversion right was determined  using  the Black-Scholes option-pricing model.
The  model  uses  several  assumptions  including:   historical   stock   price
volatility,  risk-free interest rate, remaining maturity, and the closing price
of the Company's  common  stock  to  determine  estimated  fair  value  of  the
derivative  liability.  In  valuing  the holder's conversion right at March 31,
2005, the company used the closing price  of  $0.50  and  the exercise price of
$0.50. For the nine months ended September 30, 2005, the estimated value of the
holder's  conversion right decreased to $12,018, thus the company  recorded  an
"other income"  item on the consolidated statement of operations for the change
in fair value of the holder's conversion right of $17,099.

The recorded value  of  the  holder's conversion right related to the Notes can
fluctuate  significantly based  on  fluctuations  in  the  fair  value  of  the
Company's common stock.

COMPANY'S CALL OPTION ON DEBT

Pursuant to  the terms of the Notes, the Company has the ability to The Company
has the option  of  prepaying  the  outstanding Principal Amount in whole or in
part,  by paying to the Holder a sum of  money  equal  to  one  hundred  twenty
percent  (120%)  of  the Principal Amount to be redeemed, together with accrued
but unpaid interest thereon and any and all other sums due.

The company's call option represents an embedded derivative that is required to
be accounted for apart  from  the  underlying  Notes.  At issuance of the Notes
(3/31/2005), the company's call option had an asset value  of $0. In subsequent
periods,  if  the  price  of  the  security  changes,  the embedded  derivative
financial instrument related to the company's call option  will  be adjusted to
fair value with the corresponding charge or credit to other expense  or income.
The estimated fair value of the holder's conversion right was determined  using
the  Black-Scholes  option-pricing  model.  The  model uses several assumptions
including:  historical  stock  price  volatility,  risk-free   interest   rate,
remaining  maturity,  and  the  closing  price of the Company's common stock to
determine estimated fair value of the derivative asset. In valuing the holder's
conversion right at March 31, 2005, the company used the closing price of $0.50
and the exercise price of $0.50. For the nine  months ended September 30, 2005,
the  estimated  value  of  the company's call option  was  still  $0,  thus  no
adjustment was made to add the asset to the balance sheets.

The recorded value of the company's  call  option  related  to  the  Notes  can
fluctuate  significantly  based  on  fluctuations  in  the  fair  value  of the
Company's common stock.

				F-8



NOTE 5 - RECEIVABLE FROM NUTEK OIL - ASSET HELD FOR SALE

On  April  14,  2005,  DSEN filed a Current Report on Form 8-K, relating to the
conversion of the South  Texas  Oil  Company asset held for sale into shares in
South Texas Oil Company (formerly known  as Nutek Oil) and will be distributing
its ownership interest in South Texas Oil Company to shareholders of DSEN.

The  dividend  will  take  the  form  of  a dividend  certificate  representing
restricted  common  stock,  which  will  be distributed  to  DSEN's  beneficial
stockholders of record as of the record date of April 27, 2005.

The stock dividend will be distributed to  owners  of DSEN's common stock as of
the  record  date  in  a  ratio of one share of South Texas  Oil  Company,  for
approximately every 18 shares of common stock held in DSEN.

On December 31, 2004 the company reviewed any need for impairment of assets per
SFAS 144. A loan is considered  impaired  if  it  is probable that the creditor
will be unable to collect all amounts due under the  contractual  terms  of the
loan  agreement.  In evaluating the impairment of the assets of the company  at
year end, the company  considered,  among  other  items, (1) materiality of the
asset,  (2)  previous  loss experience, and (3) assets  that  are  not  readily
marketable or susceptible to decline in value.

After discussions with the  Board and with the management of both Datascension,
and Nutek Oil, it was determined  to be in the best interest of the Company and
shareholders for the note to be converted  to  stock  and  distributed  to  the
shareholders.

Pursuant  to  the previous dividends on August 1, 2001 and January 8, 2004, the
company determined  it was in the best interest of it's shareholders to convert
the balance of the note  into  the common stock of Nutek Oil and distribute the
pro rata shares to our shareholders.  This  coincides  with managements plan to
write off any assets which are attributable to the history of the company which
are non-operational in nature, etc.

As  of  the  December  31,  2004,  the  value  of the loan to be  converted  is
$1,015,014 and is classified on the balance sheet  of  the  Company as an Asset
Held For Sale.

The stock of Nutek Oil traded over $1.00 during the week of the  conversion  to
settle  the  debt  owed  to Datascension. The stock has since traded as high as
$1.25.  Management felt strongly  that  the shareholders and company were never
at  risk of losing the value of the receivable.   When  Datascension  made  the
agreement  to convert the receivable into the stock of Nutek Oil, it was agreed
to be converted  at  the  $1,015,014  value  of  stock.  The  number  of shares
(957,349)  was only later determined based on the then average price of  $1.06.
Management did  not  feel  there was a risk of shareholders receiving less than
full credit for the value of the note.

NOTE 6 - STOCKHOLDERS' EQUITY

During the nine months ended  September  30, 2005, DSEN issued securities using
the  exceptions  available  under  the  Securities   Act   of   1933  including
unregistered sales made pursuant to Section 4(2) of the Securities  Act of 1933
as follows:

On March 31, 2005, 500,000 shares of restricted common stock valued at $.50 per
share  were issued pursuant to a consulting agreement in connection with  which
we are to  receive  certain  investor  relations services. The shares have been
issued for a two year contract which can  be cancelled after the first year and
50%  of  the  shares  returned.  The issuance of  these  securities  was  in  a
transaction deemed to be exempt under  Section  4(2)  of  the Securities Act of
1933  as  a  sale  of  securities not involving a public offering.  We  made  a
determination that the consultant  was  a  sophisticated  investors with enough
knowledge and experience in business to evaluate the risks  and  merits  of the
investment.

				F-9


On March 31, 2005, 300,000 shares of restricted common stock valued at $.50 per
share  were  issued pursuant to a consulting agreement in connection with which
we are to receive  certain  investor  relations  services. The shares have been
issued for a two year contract which can be cancelled  after the first year and
50%  of  the  shares  returned.  The  issuance  of these securities  was  in  a
transaction deemed to be exempt under Section 4(2)  of  the  Securities  Act of
1933  as  a  sale  of  securities  not  involving  a public offering. We made a
determination  that the consultant was a sophisticated  investors  with  enough
knowledge and experience  in  business  to evaluate the risks and merits of the
investment.

On March 31, 2005, DSEN issued a $125,000  Convertible Debenture, pursuant to a
Securities Purchase Agreement (the "Agreement")  to  the  Longview Fund LP.  In
addition, DSEN issued a common stock purchase warrant to purchase  300,000 post
reverse shares of DSEN common stock at an exercise price of $.50 per share. The
issuance  of  these  securities was in a transaction deemed to be exempt  under
Section 4(2) of the Securities  Act  of  1933  as  a  sale  of  securities  not
involving  a  public  offering. We made a determination that the investors were
sophisticated investors  with  enough  knowledge  and experience in business to
evaluate  the  risks  and  merits  of  the  investment as  well  as  accredited
investors. (See Note 4)

On March 31, 2005, 50,000 shares of restricted  common stock valued at $.50 per
share were issued pursuant to a consulting agreement  in  connection with which
we are to receive certain investor relations services. The  issuance  of  these
securities  was  in a transaction deemed to be exempt under Section 4(2) of the
Securities Act of 1933 as a sale of securities not involving a public offering.
We made a determination  that the consultant was a sophisticated investors with
enough knowledge and experience in business to evaluate the risks and merits of
the investment.

On March 31, 2005, 100,000 shares of restricted common stock valued at $.50 per
share were issued pursuant  to  an  employee  in connection with his employment
agreement  which  offered the executive a 100,000  share  signing  bonus.   The
issuance of these securities  was  in  a  transaction deemed to be exempt under
Section  4(2)  of  the Securities Act of 1933  as  a  sale  of  securities  not
involving a public offering.  We made a determination that the consultant was a
sophisticated investors with enough  knowledge  and  experience  in business to
evaluate the risks and merits of the investment.

All of these transactions were exempt from the registration requirements of the
Securities Act of 1933, as amended, by virtue of the exemptions provided  under
section 4(2) was available because:

  -   The  transfer  or  issuance  did  not  involve underwriters, underwriting
discounts or commissions;
  -  The  shares  were  purchased for investment purposes  without  a  view  to
distribution;
 - A restriction on transfer legend was placed on all certificates issued;
 - The distributions did not involve general solicitation or advertising; and,
 - The distributions were  made  only  to  insiders,  accredited  investors  or
investors   who  were  sophisticated  enough  to  evaluate  the  risks  of  the
investment. Each  shareholder  was  given  access  to all information about our
business  and the opportunity to ask questions and receive  answers  about  our
business from our management prior to making any investment decision.

NOTE 7 - RELATED PARTY TRANSACTIONS

As of September  30, 2005, the Company has an outstanding note payable to Scott
Kincer, the Company's  COO,  in  the  amount  of  $9,000.  This payable accrues
interest at 1% monthly due on the first day of each month.

NOTE 8 - FOREIGN OPERATIONS

The  company currently operates out of the United States, Costa  Rica  and  the
Dominican  Republic. The future plans of the company involve the slowing growth
at  the Dominican  Republic  facility  while  focusing  on  the  potential  and
available  growth  in  Costa Rica. Management does not feel there is a currency
risk or need to assess a  foreign  currency  translation  adjustment  or  other
comprehensive income item as income and expense items are negotiated in the  US
dollar. The Company maintains their accountings records in U.S. dollars and all
payments  are  made  in  US  dollars.  All debts and assets on the books of the
company are valued based on US dollars and  are  not  translated from a foreign
currency amount. The Company currently coordinates all  foreign operations, and
supervision  activities  using  part time employees, consultants  and  contract
labor. Approximately 85% of the company's  workforce  is  outside of the United
States.  Currently 100% of the company's clients are US based  companies.   Any
resulting foreign exchange fluctuations do not affect the payment of employees,
contract labor or off shore operations.

NOTE 9 - RESTATEMENT OF FINANCIAL STATEMENTS

The company  is  currently  evaluating the requirements to possibly restate the
financial statements for the  year  ended December 31, 2004, as well as for the
1st and 2nd quarter filing for 2005.  The reason for this restatement is due to
the  company's  revised  valuation  and  treatment  of  the  convertible  debt,
warrants, and derivative liabilities related  to  the  November  2004 and March
2005 convertible debt.

				F-10






                                       4


Item 2. Management's Discussion and Analysis of Financial Condition and Results
of Operations.

      The following is a discussion of certain factors affecting DSEN's results
of operations, liquidity  and  capital resources. You should read the following
discussion  and  analysis in conjunction  with  the  Registrant's  consolidated
financial statements  and  related  notes that are included herein under Item 1
above.

Overview

      Datascension  Inc,  ("DSEN") through  its  sole  subsidiary  Datascension
International, Inc, is engaged  in  data  gathering  and  conducting outsourced
market research. Its expertise is in the collection, storage, and processing of
data.   Datascension  International's  management  team has over  30  years  of
experience in working with clients to gather the information  they need to make
changes  or  advancements  to  their  operations.   Datascension  International
services  a  variety  of  industries  and customers (including the hospitality,
entertainment, and automotive sectors) with emphasis and commitment to customer
service, quality assurance and on-time project management.

Critical Accounting Policies and Estimates

      Our  discussion  and  analysis  of financial  condition  and  results  of
operations is based upon our financial  statements, which have been prepared in
accordance with accounting principles generally  accepted  in the United States
of America. The preparation of these financial statements requires  us  to make
estimates   and   judgments   that  affect  the  reported  amounts  of  assets,
liabilities, revenue and expenses,  and related disclosure of contingent assets
and liabilities. On an ongoing basis,  we  evaluate  our estimates. We base our
estimates  on historical experience and on various other  assumptions  that  we
believe  to  be   reasonable  under  the  circumstances.  These  estimates  and
assumptions provide  a  basis for making judgments about the carrying values of
assets and liabilities that are not readily apparent from other sources. Actual
results  may  differ  from  these  estimates  under  different  assumptions  or
conditions, and these differences may be material.

      We believe the following  critical  accounting  policies  affect its more
significant judgments and estimates used in the preparation of its consolidated
financial statements.

Foreign Currency

      DSEN  maintains  its accounting records in U.S. dollars and all  payments
are made in US dollars.   Any  resulting  foreign  exchange fluctuations do not
affect the payment of employees, contract labor or off shore operations.

Revenue Recognition.

      We  recognize revenues when survey data is delivered  to  the  client  in
accordance  with  the  terms of our agreements. Research products are delivered
within a short period, generally ranging from a few days to approximately eight
weeks. An appropriate deferral is made for direct costs related to contracts in
process, and no revenue  is  recognized  until  delivery  of the data has taken
place.  Billings rendered in advance of services being performed,  as  well  as
customer  deposits  received  in  advance,  are recorded as a current liability
included in deferred revenue. We are required  to  estimate contract losses, if
any,  and  provide  for  such  losses  in the period they  are  determined  and
estimable.  We do not believe that there  are  realistic  alternatives  to  our
revenue recognition  policy  given the short period of service delivery and the
requirement to deliver completed surveys to our
                                          5



customers. We do not believe there  is  significant risk of recognizing revenue
prematurely since our contracts are standardized, the earnings process is short
and no single project accounts for a significant portion of our revenue.

DSEN's website address is http://www.datascension.com.

Results of Operations

      Analysis of the quarter ended September  30, 2005 compared to the quarter
ended September 30, 2004.

For the three-months, ended September 30, 2005,  DSEN  has generated $2,365,454
in  revenues  compared  to  $2,101,033  in revenues for the three-months  ended
September 30, 2004, for an increase of $264,421.   The increase in revenue is a
result of an increase in new clients, and an increase  in  our  hourly  billing
rates.

Cost of goods sold for the three-months ended September 30, 2005 was $2,127,257
compared  to  $1,663,996  for  the  three-months ended September 30, 2004 or an
increase of $463,261.  This increase  is  a  result  in  an  increased  cost of
payroll, along with an increase in work with clients.

Total  general and administrative expenses increased to $560,697 for the three-
months ended  September  30,  2005  from  $371,393  for  the three-months ended
September 30, 2004, a net increase of $189,304.  This increase  is  related  to
the  increased  insurance  costs,  travel  expenses and administrative overhead
costs.

Depreciation expense for the three-months ended  September 30, 2005 was $44,888
compared to $85,646 for the three-months ended September  30,  2004, a decrease
of $40,758. The decrease resulted from the disposal and write down of assets in
the fourth quarter of 2004.

Interest  expense  for  the  three-months ended September 30, 2005 was  $64,671
compared to $20,697 for the three-months  ended  September 30, 2004 an increase
of $43,974.  This increase is due to the amortization  of  the  financing costs
and additional interest cost related to the purchase of predictive dialers.

Datascension  generated  a  net  loss  of  $572,334 for the three months  ended
September 30, 2005, versus net income of $16,651  for  the same period in 2004.
The increase in losses of $588,985 is a result of the increased  payroll costs,
as  well  as  the  increased  expenses  related  to the value of the derivative
liabilities associated with the convertible financing  the  company received in
November 2004, and March 2005.  For the nine months ended September  30,  2005,
DSEN  has  decreased  its  working capital position by a net amount of $266,871
from positive $566,816 as of  December 31, 2004 to $299,945 as of September 30,
2005.  This is due to a decrease  in cash of $352,869, as well as a decrease in
accounts receivable of $14,443 and  a decrease in prepaid expenses of $173,375,
while there was also a decrease in current liabilities of $273,816.

Significant Subsequent Events occurring after September 30, 2005:

      None.








                                       6


Capital Resources and Liquidity

Liquidity

Management believes that its current client contracts and receivables will meet
its minimum general and administrative  cost requirements and provide the basic
liquidity Datascension needs to operate at  current levels over the next twelve
months.  However, additional funding will be  needed to cover the expenses over
the next several months related to the expansion  of  our facilities and hiring
and training of new employees.

For the nine months ended September 30, 2005, DSEN has  decreased  its  working
capital  position  by  a  net  amount  of $266,871 from positive $566,816 as of
December 31, 2004 to $299,945 as of September  30,  2005.   This  is  due  to a
decrease  in  cash of $352,869, as well as a decrease in accounts receivable of
$14,443 and a decrease  in prepaid expenses of $173,375, while there was also a
decrease in current liabilities of $273,816.

Capital Resources

    The Registrant's capital  resources  are  comprised  primarily  of  private
investors, including members of management, who are either existing contacts of
Datascension's  management  or  who  come  to  the  attention of the Registrant
through    brokers,    financial   institutions   and   other   intermediaries.
Datascension's access to  capital  is  always  dependent upon general financial
market conditions, especially those which pertain to venture capital situations
such as oil and gas exploration companies.

      On September 30, 2005 DSEN had total assets  of  $4,563,623  compared  to
$7,678,870 on September 30, 2004, a decrease of $3,115,247.  The reason for the
decrease in assets is a result of the decrease in prepaid expenses of $218,366,
an increase in accounts receivable of $233,055, an increase in cash of $69,423,
as  well  as a decrease in deposits of $8,151, and a decrease in website assets
of $25,070,  along  with  the write down of assets at year end 2004. DSEN had a
total stockholders' equity  of  $558,993  on  September  30,  2005  compared to
$6,262,797 on September 30, 2004, a decrease in equity of $5,703,804,  which is
in part due to the $1,015,014 conversion and distribution of the DSEN's loan to
Nutek  Oil,  Inc., the write down of discontinued operations of $1,731,001,  as
well as the distribution  of  the Company's ownership in Century Innovations of
$976,221.

      All assets are booked at  historical  purchase  price  and  there  is  no
variance between book value and the purchase price.

      On  September  30,  2005  DSEN  had  Property  and  Equipment of $995,543
compared to $1,769,148 on September 30, 2004, or a decrease  of  $773,605 which
is  a  result  of the write off of property and equipment at the end  of  2004,
along with a offsetting  purchase  of  predictive  dialers  during the 9 months
ended September 30, 2005.

      As  discussed  above  DSEN  intends  to  meet  its  financial  needs  for
operations  through  the  collection  of  accounts receivable and servicing  of
current contracts.

      DSEN's capital resources are comprised  primarily  of  private investors,
who are either existing contacts of the Registrant's management  or who come to
the  attention  of  the Registrant through brokers, financial institutions  and
other intermediaries.  The  Registrant's  access to capital is always dependent
upon general financial market conditions. The  Registrant's  capital  resources
are not anticipated to change materially in 2005.

      DSEN   has  financed  operations  through  the  collections  of  accounts
receivable, servicing  of  existing  contracts and the sale of common stock and
through financing from financial institutions.  In  order to sustain operations
in  the near term, it is anticipated that DSEN has sufficient  working  capital
due to  the fact that on November 17, 2004, we issued $1,875,000 in convertible
notes, receiving net proceeds of $1,657,500.

      DSEN's  future  capital  requirements  will  depend  on numerous factors,
including the profitability of our research projects and our ability to control
costs.  We  believe  that  our current assets will be sufficient  to  meet  our
operating expenses and capital  expenditures.  However,  we cannot predict when
and if any additional capital contributions may be needed  and  we  may need to
seek  one  or  more  substantial  new  investors.  New  investors  could  cause
substantial dilution to existing stockholders.

      There  can  be  no  assurances  that  DSEN  will be successful in raising
additional capital via debt or equity funding, or that  any  such transactions,
if  consummated,  will  be  on  terms  favorable  to  DSEN.  In the event  that
additional capital is not obtained from other sources,  it may become necessary
to alter development plans or otherwise abandon certain ventures.

      If  DSEN  needs  to  raise additional funds in order to  fund  expansion,
develop new or enhanced services or products, respond to competitive  pressures
or acquire complementary products,  businesses  or technologies, any additional
funds raised through the issuance of equity or convertible debt securities, the
percentage ownership of the stockholders of DSEN  will be reduced, stockholders
may  experience  additional  dilution  and  such securities  may  have  rights,
preferences or privileges senior to those of  DSEN's  Common  Stock.  DSEN does
not currently have any contractual restrictions on its ability  to  incur  debt
and,  accordingly,  DSEN  could  incur  significant  amounts of indebtedness to
finance its operations.  Any such indebtedness could contain  covenants,  which
would restrict DSEN's operations.
                                          7


Off-Balance Sheet Arrangements.

      DSEN currently does not have any off-balance sheet arrangements.

Forward-Looking Information

      This  quarterly  report contains forward-looking statements. The forward-
looking statements include all statements that are not statements of historical
fact. The forward-looking  statements  are  often  identifiable by their use of
words  such  as  "may," "expect," "believe," "anticipate,"  "intend,"  "could,"
"estimate," or "continue," "Plans" or the negative or other variations of those
or comparable terms.  Our  actual  results  could  differ  materially  from the
anticipated  results described in the forward-looking statements. Factors  that
could affect our  results  include,  but are not limited to, those discussed in
Item  2,  "Management's  Discussion and Analysis  or  Plan  of  Operation"  and
included elsewhere in this  report.   DSEN  makes  no  commitment to update any
forward-looking  statement or to disclose any facts, events,  or  circumstances
after the date hereof  that  may  affect  the  accuracy  of any forward-looking
statement.

Item 3. Controls and Procedures.

      (a)  Our  Chief Executive Officer (CEO) and Principal  Financial  Officer
evaluated the effectiveness  of  our  disclosure  controls  and  procedures (as
defined  in  Rules  13a-15(e) and 15d-15(e) of the Securities Exchange  Act  of
1934, as amended) as  of  the  end  of the period covered by this report. Based
upon the evaluation, concluded that the  disclosure controls and procedures are
effective in ensuring all required information  relating to DSEN is included in
this quarterly report.

      We also maintain a system of internal control  over  financial  reporting
(as  defined  in  Rules 13a-15(f) and 15d-15(f)) designed to provide reasonable
assurance regarding  the reliability of financial reporting and the preparation
of financial statements  for  external  purposes  in accordance with accounting
principles generally accepted in the United States of America.

      (b)   Changes  in  internal  controls.   During our  most  recent  fiscal
quarter,  there  have been no changes in our internal  control  over  financial
reporting that occurred  that have materially affected or are reasonably likely
to materially affect our internal control over financial reporting.


                            PART II. OTHER INFORMATION

Item 1. Legal Proceedings.

      DSEN is not a party  to  any  pending  material  legal proceeding. To the
knowledge  of  management,  no federal, state or local governmental  agency  is
presently  contemplating any proceeding  against  DSEN.  To  the  knowledge  of
management,  no  director, executive officer or affiliate of DSEN, any owner of
record or beneficially  of  more  than  5%  of  DSEN's  common stock is a party
adverse to DSEN or has a material interest adverse to DSEN in any proceeding.

Item 2. Unregistered Sales of Equity Security and Use of Proceeds.

      None.

Item 3.  Defaults Upon Senior Securities

      None.

Item 4.  Submission of Matters to a Vote of Security Holders

      None.

Item 5.  Other Information

      None.

Item 6.  Exhibits and Reports on Form 8-K

Exhibits

      (a)  Exhibit 31. Certifications required by Rule 13a-14(a)  or  Rule 15d-
14(a)

     31.1  Certification  of  Chief  Executive  Officer and Principal Financial
Officer pursuant to 18 U.S.C.ss.1850 as adopted pursuant  to Section 302 of the
Sarbanes-Oxley Act of 2002.

      (b)  Exhibit 32. Certifications required by Rule 13a-14(b)  or  Rule 15d-
14(b) and section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350

     32.1  Certification  of  Chief  Executive  Officer and Principal Financial
Officer pursuant to 18 U.S.C.ss.1850 as adopted pursuant  to Section 906 of the
Sarbanes-Oxley Act of 2002.

Reports on Form 8-K

None

                                         10




SIGNATURES

      In  accordance  with  Section  13  or  15(d)  of  the Exchange  Act,  the
registrant caused this report to be signed on its behalf  by  the  undersigned,
thereunto duly authorized.

                                  Datascension, Inc.

                                  /s/ Scott Kincer
                                  ----------------------
                                  Scott Kincer
                                  President, Chairman and Director
                                  (Principal Executive Officer)

                                  /s/ Scott Kincer
                                  -------------------
                                  Scott Kincer
                                  (Principal Financial Officer)

                                  Date: November 21, 2005

      Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on  its behalf
by the undersigned, thereunto duly authorized.

                                  /s/ Scott Kincer
                                  ----------------------
                                  Scott Kincer
                                  President, Chairman and Director
                                  (Principal Executive Officer)


                                      11


                                  /s/ Scott Kincer
                                  -------------------
                                  Scott Kincer
                                  (Principal Financial Officer)

                                  Date: November 21, 2005












                                      12